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Abstract 
The global burden of stroke is huge and increasing despite significant 
improvements in acute stroke care in recent decades. The indirect costs, such as 
productivity losses due to patients’ inability to return to work after stroke, are a 
major factor in the accumulation of this burden and are estimated to outweigh 
the direct costs of stroke. 
Post-stroke cognitive impairments seem to relate intimately to functional 
outcomes and quality of life after stroke, but their role in the creation of stroke-
related productivity losses remains uncertain. The aim of this study was 
threefold: to compare the prevalence and severity of post-stroke cognitive 
impairments in relation to the severity of clinical neurological impairments; to 
specify the role of cognitive impairments in patients’ ability to return to work 
after stroke; and to assess the use of stroke-related income supplements and the 
role of cognitive impairments in supplement use.  
A consecutive cohort of 230 working-aged patients with a first-ever ischaemic 
stroke was enrolled in two Finnish hospitals. The patients underwent repeated 
neuropsychological assessments in order to describe their cognitive sequelae. 
Cognitive data from baseline, six-month and two-year follow-up examinations 
were analysed in relation to demographic, clinical and occupational information 
on the patients. Cognitive impairments were defined based on the performance 
of a healthy demographic control group (N =50). 
Cognitive impairments frequently appeared among otherwise intact patients. 
After taking into account other relevant factors, baseline cognitive impairments 
most effectively predicted the return to work of the patients six months after the 
stroke. Regarding the use of stroke-related income supplements, atrial 
fibrillation was the most effective health-related predictor, and cognitive 
impairments the most effective stroke-related predictor.  
The results of the study emphasize the usefulness of early neuropsychological 
assessments in treatment planning and the importance of cognitive 
impairments in the accumulation of post-stroke productivity losses. 
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Tiivistelmä 
Aivoinfarktin akuuttihoidon kehitys kuluneiden vuosikymmenten aikana on 
ollut erittäin merkittävää. Aivoinfarkti on silti yhä yksi yhteiskunnallisesti 
merkittävimmistä sairauksista siihen liittyvän kuolleisuuden ja vammaisuuden 
vuoksi. Aivoinfarktin vuoksi menetetään enemmän laatupainotteisia elinvuosia 
kuin minkään muun sairauden vuoksi. Vaikka kehittyneissä maissa 
aivoinfarktiin sairastuneista vain joka neljäs on työikäinen, ovat juuri työikäiset 
yhteiskunnallisesti erityisen merkittävä aivoinfarktipotilasryhmä heihin 
keskittyvien sairastumisen epäsuorien kustannusten, erityisesti tuottavuuden 
menetyksien vuoksi.  
Työikäisten potilaiden paluu työhön sairastumisen jälkeen on keskeinen 
aivoinfarktin epäsuoriin kustannuksiin vaikuttava tekijä. Kaikki työikäiset eivät 
kuitenkaan ole työelämässä, ja työhön paluukin on työikäisten tuottavuuden 
muutoksia peilaavana mittarina osin riittämätön. Aivoinfarktin aiheuttaman 
yhteiskunnallisen taakan ymmärtämiseksi tarvitaan entistä kattavampia tapoja 
arvioida aivoinfarktin seurauksia työikäisille potilaille. Useissa maissa käytössä 
olevat, sairauden aiheuttaman haitan perusteella myönnettävät 
yhteiskunnalliset etuisuudet ovat osa aivoinfarktin epäsuoria kustannuksia, 
liittyvät tuottavuuden muutoksiin ja koskevat sekä työelämässä että sen 
ulkopuolella olevia potilaita.  
Tutkittaessa aivoinfarktin aiheuttamia haittoja arjen toimintakyvyssä, 
elämänlaadussa ja mielialassa näyttää neuropsykologisilla häiriöillä olevan 
keskeinen merkitys. Työikäisten potilaiden tuottavuuden muutosten osalta tieto 
neuropsykologisten häiriöiden merkityksestä on yhä vähäistä.  
Tämän työn tavoitteena on kuvata kliinisesti merkittävien 
neuropsykologisten häiriöiden yleisyyttä työikäisillä aivoinfarktipotilailla. 
Lisäksi tutkimuksessa selvitetään, mikä merkitys neuropsykologisilla häiriöillä 
on työikäisten potilaiden paluuseen työhön ja aivoinfarktiin liittyvien 
yhteiskunnallisten etuisuuksien käyttöön, huomioiden muut hoidon 
lopputulokseen vaikuttavat tekijät. 
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Tässä kliinisessä seurantatutkimuksessa seurattiin 230 Helsingin ja 
Uudenmaan sairaanhoitopiirin ja Lapin sairaanhoitopiirin alueella 
sairastunutta työikäistä aivoinfarktipotilasta. Potilaista kerättiin oleelliset 
tausta-, työtilanne- ja lääketieteelliset tiedot, ja neuropsykologisilla 
tutkimuksilla seurattiin potilaiden neuropsykologista oireistoa ja siitä 
toipumista ensimmäisistä viikoista aina kahteen vuoteen sairastumisesta. 
Kansaneläkelaitoksen ja Eläketurvakeskuksen rekisteritiedoista kerättiin tiedot 
potilaille maksetuista etuisuuksista sairastumisen jälkeisiltä kolmelta vuodelta. 
Neuropsykologisten häiriöiden esiintymistä verrattiin muiden neurologisten 
oireiden esiintymiseen, työhön palaamiseen ja aivoinfarktin aiheuttamaan 
yhteiskunnallisten tukien käyttöön. 
Kliinisesti merkittäviä neuropsykologisia häiriöitä havaittiin yleisesti jopa 
muutoin neurologisesti oireettomilla potilailla. Mallinnettaessa potilaiden 
työhön paluun onnistumiseen vaikuttavia tekijöitä neuropsykologiset häiriöt 
olivat merkityksellisin tekijä. Jokainen sairastumisen jälkeisen viikkojen aikana 
todettu neuropsykologinen häiriö yli kaksinkertaisti potilaiden riskin olla 
työkyvytön puoli vuotta sairastumisen jälkeen. Mallinnettaessa aivoinfarktin 
perusteella myönnettyjen yhteiskunnallisten etuisuuksien käyttöä todettiin 
sydämen eteisvärinän olevan tärkein terveyteen liittyvä tukien käyttöä 
ennustava tekijä. Tärkein aivoinfarktiin liittyvä tukien käyttöä ennustava tekijä 
oli neuropsykologinen oireisto. Aineiston työikäiset potilaat käyttivät 
aivoinfarktin vuoksi myönnettyjä tukia keskimäärin lähes 12 kk ajan. 
Tutkimus vahvistaa käsitystä varhain toteutetun neuropsykologisen 
arvioinnin hyödyllisyydestä osana aivoinfarktipotilaan akuuttivaiheen 
moniammatillista toimintakykymuutosten arviota. Tutkimus tarjoaa uutta 
tietoa neuropsykologisen jälkioireiston yleisyydestä muutoin vähäoireisilla 
potilailla. Tutkimus tarjoaa uutta tietoa myös neuropsykologisen jälkioireiston 
merkityksestä aivoinfarktipotilaiden työhön paluulle. Tutkimuksen perusteella 
neuropsykologinen jälkioireisto vaikuttaa merkittävästi aivoinfarktin 
epäsuorien kustannusten muodostumiseen.   
 
 
8 
Acknowledgements 
This project was completed during many years of part-time research, 
interrupted by clinical work and family life. During this journey, I have had a 
privilege to meet, collaborate and work with, get help from, and be supported by 
many people who deserve my sincere thanks. 
First and foremost I wholeheartedly thank my supervisor Erja Poutiainen. 
Erja accepted me as a member to the AINO research group. She taught and 
showed how to navigate through the research bureaucracy when expanding the 
research project from Helsinki University Central Hospital to Lapland Central 
Hospital. At all times she provided me with fast, accurate and insightful 
comments and advice. She withstood when my patience with details was nearly 
overrun by my generality. At the same time, she gave me the time and 
independence I needed to balance my resources between research, clinical work 
and family.  
I would not have managed without the support I got from Väinö, which is not 
a person but a nickname referring to the doctoral students of the AINO group. 
Siiri Laari and Katri Turunen were my closest collaborators, with whom I have 
spent countless hours planning, wondering, sharing ideas, views, literature, 
syntax, despair and success as well. I will miss those long lunch breaks, thank 
you for your invaluable help and existence.  
I sincerely thank all other members of AINO project for pleasant and effective 
collaboration: psychologists Johanna Itkonen-Hannikainen, Marjatta Melkas, 
Riikka Pihlaja, Johanna Stenberg, Taru Taurén, Jenni Uimonen and Tanja 
Vihavainen; neurologist Satu Mustanoja for aetiological and radiological 
classifications and invaluable medical insights; neurologists Peter Baumann and 
Turgut Tatlisumak for support and for engaging as medically accountable 
persons in the research project needed both in Helsinki and Rovaniemi. 
I am indebted to Jari Lipsanen from the Institute of Behavioural Sciences, 
University of Helsinki, for several statistical consultancies, which were pivotal to 
this project. 
 
 
9 
I owe my deep gratitude to all personnel of Helsinki University Central 
Hospital and Lapland Central Hospital, Department of Neurology and Clinical 
Neurophysiology, who have participated in the care of AINO patients or data 
collection, or otherwise helped me with innumerable practical issues. I am 
especially indebted to Eva Salomaa, former Medical Director of Lapland 
Hospital District, who was without exception always kind, active and clear in the 
administrative and permit process related to incorporating the AINO project to 
Lapland Hospital District. As an employer, Lapland Hospital District has been 
abundantly supportive and committed to my doctoral studies. 
I am honoured to have professor Teija Kujala as my supervisor in charge of 
supervision and as a Custos at the public defence of this thesis. I thank sincerely 
my pre-examination reviewers, Professor Edward de Haan and Docent Heikki 
Numminen, for engaging in my work and encouraging and insightful comments. 
I am very delighted to have docent Mervi Jehkonen as the Opponent at the 
public defence of this thesis.  
I express my gratitude for the financial support of this work from the Finnish 
Cultural Foundation, The Social Insurance Institution of Finland (Kela) and 
National Research Fund (VTR) via Lapland Hospital District. Ilona Autti-Rämö, 
Annamari Tuulio-Henriksson and Tiina Telakivi and many others from Kela 
Research Department provided also intellectual support by sharing their 
knowledge and commenting AINO project’s results. 
Special thanks go to Maria Hautala, who kindly borrowed me her office 
providing me a peaceful environment to put this work all together last fall, and 
Zoe Koivu, who was able to help me with English language when no one else 
could.  
Finally, the warmest gratitude goes to my family and friends, who have been 
there all the time, making sense and continuity. Thank you Viveka. For 
everything. Thank you Petja, Mitja and Liia, it has been a privilege to see how 
you evolve and become yourselves.  
  
 
 
10 
List of original publications 
This thesis is based on the following original publications, referred to in the text 
by Roman numerals I-III. 
 
I  Kauranen T., Laari S., Turunen K., Mustanoja S., Baumann P. & 
Poutiainen E. (2014). The cognitive burden of stroke emerges even with an 
intact NIH Stroke Scale Score; a cohort study. Journal of Neurology, 
Neurosurgery & Psychiatry, 85, 295–299. 
II  Kauranen T., Turunen K., Laari S., Mustanoja S., Baumann P. & 
Poutiainen E. (2013). The severity of cognitive deficits predicts return to work 
after a first-ever ischemic stroke. Journal of Neurology, Neurosurgery & 
Psychiatry, 84, 316–321. 
III Kauranen T., Laari S., Turunen K., Melkas M., Mustanoja S., Baumann P. 
& Poutiainen E. (2015). Use of stroke-related income supplements and 
predictors of use in a working-aged Finnish Ischemic stroke cohort. Journal of 
Stroke and Cerebrovascular Diseases, 24, 1715–1723. 
 
The articles are reprinted with the kind permission of the copyright holders. 
 
 
11 
Abbreviations 
CT    Computed Tomography 
DF    Degrees of freedom 
GCS    Glasgow Coma Scale 
ETK    Finnish Centre for Pensions 
HR    Hazard ratio 
IBM    International Business Machines 
KELA   Finnish Social Insurance Institution 
M     Mean 
MRI    Magnetic Resonance Imaging 
mRS    modified Rankin Scale 
NIHSS   National Institutes of Health Stroke Scale 
OR    Odds ratio 
POMS   Profile of Mood States 
QALY   Quality-adjusted life year 
SD    Standard deviation 
SPSS   Statistical Package for Social Sciences 
WAIS-III  Wechsler Adult Intelligence Scale, Third Edition 
WMS-R  Wechsler Memory Scale Revised  
 
 
12 
1 Introduction 
1.1 The global burden of stroke 
Ischaemic stroke refers to a sudden loss of blood circulation to an area of the 
brain, which results in ischemia, nerve cell death and a corresponding loss of 
neurological function (Sacco et al., 2013). Broadly, stroke also refers to 
intracerebral and subarachnoid haemorrhages, but in this presentation, 
ischemic stroke is intended unless otherwise specified.  In 2005, 16 million new 
strokes occurred worldwide causing almost six million deaths and forcing 
another five million survivors with their families and communities to cope with 
permanent disability (Mackay, Mensah, World Health Organization, & Centers 
for Disease Control and Prevention (U.S.), 2004). In many developed countries, 
stroke is a leading cause of adult disability and takes more quality-adjusted life-
years (QALY) than any other disease. Disability after stroke derives from motor, 
sensory and cognitive impairments challenging survivors’ physical, 
psychological and social well-being.  
Direct and indirect costs of stroke in Europe in 2010 were estimated at 63 
billion euros, and in the US, 74 billion dollars (Gustavsson et al., 2011). By 
2030, 23 million new strokes are estimated to occur (Mackay, Mensah, World 
Health Organization, & Centers for Disease Control and Prevention (U.S.), 
2004). Epidemiologically, stroke is in constant change (Feigin et al., 2015). 
Despite decreasing stroke-related mortality (Koton et al., 2014), absolute 
numbers of people affected and related deaths are increasing (Feigin et al., 
2014) and thereby global stroke burden continues to increase (Feigin et al., 
2015). The developing countries bare the heaviest burden of stroke, but even in 
developed countries there are worrying trends, such as the increasing incidence 
of stroke in the working-aged population (Kissela et al., 2012; Krishnamurthi et 
al., 2015). More research is needed to establish a knowledge basis for effective 
prevention, treatment strategies, and resource allocation. 
Large-artery atherosclerosis induced emboli is the leading aetiological cause 
of ischaemic stroke with the prevalence of 40-60 %, while intra-cranial small-
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vessel disease comprises 20-35 % of all ischaemic strokes (Aivoinfarkti. Cerebral 
infarction [stroke]: Current Care Guidelines Abstract, 2011). Cardiac embolism 
is the third biggest cause of ischaemic stroke with the prevalence of 15-25 % 
(Aivoinfarkti. Cerebral infarction [stroke]: Current Care Guidelines Abstract, 
2011). Of strokes with cardiac aetiology, atrial fibrillation is by far the most 
common cause. Atrial fibrillation is still both under diagnosed and related to 
more adverse outcomes and therefore of special importance to the prevention 
and treatment of stroke (Lamassa et al., 2001). 
1.2 Cognitive impairments after stroke 
Conventionally, the focus in research on post-stroke disability has been on 
apparent physical deficits, such as loss of functional movement (for a review on 
motor recovery after stroke, see e.g. Langhorne, Coupar, & Pollock, 2009). 
Tremendous developments during the past decades in acute stroke care also 
facilitate attention to less obvious hindrances of recovery. Sometimes called 
hidden dysfunction (Jaillard, Naegele, Trabucco-Miguel, LeBas, & Hommel, 
2009), cognitive impairment after stroke is receiving growing attention, as it 
seems to relate intimately to stroke outcome. 
Cognitive impairments after stroke refer to various brain-derived 
information-processing impairments, such as deficits of attention and executive 
function, working memory, learning, calculation, visual perception, processing 
speed, visual spatial and constructional skills, and language and motor skills. 
Acute cognitive impairments develop within the first minutes from blood 
occlusion in the affected brain vessel. Due to changing perfusion conditions, 
oedema etc., acute phase impairments tend to fluctuate. After the stabilization 
of the acute phase, the sub-acute phase begins, which is considered to continue 
up to approximately three to six months after the stroke. According to 
Gottesman & Hillis (2010) review, more than two third of the patients suffer 
from cognitive impairments during the sub-acute phase. More recently, 
Schaapsmeerders et al. (2013) showed that these impairments can be highly 
persevering – approximately half of 277 stroke survivors aged < 50 years 
suffered permanent cognitive impairments even a decade after the stroke. 
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Cohort studies have linked post-stroke cognitive impairments to patients’ 
long-term cognitive outcome (Nys, van Zandvoort, de Kort, van der Worp et al., 
2005), depressive symptoms (Nys et al., 2006) and quality of life 
(Hochstenbach, Anderson, van Limbeek, & Mulder, 2001; Nys et al., 2006). 
Regarding functional outcome after stroke, there are two review studies that 
have focused specifically on cognitive impairments and emphasized cognitive 
impairments as a determinant of functional outcome after stroke (Barker-Collo 
& Feigin, 2006; Feigin, Barker-Collo, McNaughton, Brown, & Kerse, 2008), As 
such, detection of post-stroke cognitive sequelae can be seen as a prerequisite 
for developing sound rehabilitation strategies. 
Post-stroke cognitive impairments can be detected using a clinical 
neuropsychological assessment. It includes multiple tests and a focused 
interview covering a wide range of the above-mentioned cognitive functions and 
their deficits. Several issues must be specifically attended to in a study setting 
out to create a credible account to measure post-stroke cognitive impairments. 
Of particular importance are methods of deriving cut-offs for impaired 
performance, especially whether the cut-offs are grounded on demographically 
similar control data. In a clinical setting of dealing with acute patients, the 
timing of a neuropsychological assessment is also relevant to the reliability of 
the results. Expediting the assessment too much makes the assessment 
vulnerable to a patient’s fluctuating acute phase conditions, such as delirium, 
hence jeopardising the reliability of the assessment. Yet gathering all the 
outcome-related information as early as reliably possible is strongly supported 
by both basic research evidence on plasticity and clinical evidence of time-
dependent effectiveness of stroke rehabilitation (Jenkins & Merzenich, 1987; 
Kleim & Jones, 2008; Musicco, Emberti, Nappi, Caltagirone, & Italian 
Multicenter Study on Outcomes of Rehabilitation of Neurological Patients, 
2003; Salter et al., 2006). The earlier the assessment, the earlier the 
information regarding the cognitive impairments can be utilized in the 
treatment and rehabilitation of a patient. There is some evidence that early 
cognitive impairment, as occurs in the transition between acute and sub-acute 
phases of stroke, can reliably predict later outcome. Nys, van Zandvoort, de 
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Kort, van der Worp et al. (2005) assessed the prognostic value of domain-
specific cognitive abilities in 168 patients within three weeks after a first-ever 
stroke, and concluded that cognitive abilities in the early phase after stroke are 
excellent independent predictors of long-term cognitive and functional 
outcome. 
The resources required for thorough neuropsychological assessments to 
evaluate cognitive impairments vary between and within hospitals. Without 
effective neuropsychological assessments, assumptions of a stroke patient’s 
cognitive state rely on three types of less time-consuming but more or less 
insensitive factors. First, a widely-used method to gather information on 
cognitive state of stroke patients are cognitive screening tools such as Mini 
Mental State Examination (Folstein, Folstein, & McHugh, 1975), which however 
cannot be recommended due to insensitivity in the context of stroke patients 
(Nys, van Zandvoort, de Kort, Jansen et al., 2005). Second, known risk factors 
for post-stroke cognitive impairments can give a hint of a patient’s cognitive 
state. For example, an ischemia in left cerebral arteria of a right-handed patient 
is likely to cause speech problems. Correspondingly an ischemia in right 
frontoparietal areas associates with left hemispatial neglect. For a more 
comprehensive review on predictors of cognitive dysfunction resulting from 
ischaemic stroke, see Gottesman & Hillis (2010). Third, cognitive impairments 
associate with other measures of stroke severity. In general, the clinically most 
severe strokes tend to exhibit the most severe cognitive impairments as well. 
Further research is needed to describe the parallels of clinical neurological and 
cognitive impairments more specifically. Information on the relationship 
between clinical stroke severity and the severity of cognitive impairments has 
important practical implications for the management of stroke patients, both 
those symptomatic and those with successful recovery. 
1.3 Return to work after stroke 
Given that three strokes out of four attack patients who are already retired, it is 
no wonder stroke is often considered a disease of the elderly. Sometimes this 
curved age distribution seems to mask the one out of four stroke patients who 
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are in fact working-aged (for Finnish data see Meretoja et al., 2011 and for a 
more global perspective see e.g. Daniel, Wolfe, Busch, & McKevitt, 2009). In 
2013, almost 7.3 million new ischaemic strokes occurred in 20-64 year-olds 
worldwide (Krishnamurthi et al., 2015). Despite the less frequent incidence 
compared to the elderly, this younger stroke subgroup arguably presents a 
crucial patient group in the total socio-economic burden of stroke. In the core of 
this argument is the issue of whether the patients can return to work after the 
stroke.  
The socio-economic burden of stroke derives from both direct and indirect 
costs. The direct costs refer to inpatient stays, outpatient visits, rehabilitation, 
and medications, whereas the indirect costs refer to, for example, various losses 
of productivity. Demaerschalk, Hwang, & Leung (2010) conducted a systematic 
literature review to determine the costs of ischaemic stroke in US and argued 
that the indirect costs outweigh the direct costs of stroke. Most importantly, it is 
the working-aged stroke-survivors’ post-stroke inability to return to their 
former employment that so devastatingly inflates the indirect costs and, hence, 
the total socio-economic burden of stroke.  
Daniel et al. (2009) reviewed systematically the social consequences of stroke 
for working-aged adults and found that approximately half of the working-aged 
stroke patients do not return to work after the stroke. In individual studies 
evaluated in the review, the reported rates of return to work, however, varied 
between 0-100%. A major cause for the extreme variation in the return to work 
rates was the way work was defined. In order to enhance repeatability across 
studies, there is a growing trend of defining work as employment outside the 
house.  
The well-documented, most effective predictor of a stroke patient’s vocational 
outcome is stroke severity (Daniel et al., 2009; Treger, Shames, Giaquinto, & 
Ring, 2007). Depending on the study at hand, stroke severity refers to various 
measures regarding the incident stroke. The most commonly used measures are 
gross neurological and functional outcomes. The growing cognitive demands of 
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current working life necessitate a description of the relationship between the 
cognitive severity and the vocational outcome of stroke as well. 
While stroke severity may be the prevailing factor affecting the outcome of 
stroke, it is not the only one. The reasons for stroke patients’ compromised 
vocational outcome are multifaceted, and only partially related to the stroke per 
se (Howard, Till, Toole, Matthews, & Truscott, 1985). The non-stroke-related 
factors constitute from demographic and occupational factors, such as age, 
education and occupational status (Howard et al., 1985; Tanaka, Toyonaga, & 
Hashimoto, 2011; Treger et al., 2007). For example, older patients are more 
unlikely than younger patients to return to work after stroke irrespective of 
stroke severity. Similarly, lower education and occupational status both increase 
the risk of adverse vocational outcome. 
So far, the research conducted regarding the role of cognitive impairments in 
the vocational outcome of stroke survivors is sparse and methodically limited. 
There are a number of prospective cohort studies assessing post-stroke return to 
work, but typically the analysis of cognitive impairments has been either 
omitted or restricted to single grave impairments such as aphasia or neglect, 
detected in the clinical neurological examination. Most of the studies have not 
applied neuropsychological assessments, hence being capable of detecting only 
the most severe impairments (Black-Schaffer & Osberg, 1990; Howard et al., 
1985; Hsieh & Lee, 1997; Lindstrom, Roding, & Sundelin, 2009; Neau et al., 
1998; Saeki & Toyonaga, 2010). One study reported defects of intelligence and 
memory to affect vocational outcome but without parallel analysis of non-
stroke-related effectors of return to work (Kotila, Waltimo, Niemi, Laaksonen, & 
Lempinen, 1984). 
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1.4 Measuring productivity beyond employment 
However well grounded it is in stroke research to measure productivity as work, 
and work in turn as employment outside the house, this circumscription 
inevitably fails to appreciate the uncountable forms of human productivity seen 
in the real world, in the lives of individual stroke survivors. For example, 
working-aged stroke patients who are unemployed but help with the day-care 
arrangements of small grandchildren, obtain groceries for elderly parents, or 
coach a local junior football team arguably are contributing to society despite 
the lack of pay. Thus, losing the ability to participate in these activities after 
stroke could be considered a productivity loss. Nonetheless, for a research 
setting, it is highly challenging to measure variation that is so heterogenic by 
nature. Arguably, measurement of all types of stroke-related productivity losses, 
work-related or otherwise, is valuable in understanding the socio-economic 
burden of stroke. As Joo, George, Fang, & Wang (2014) conclude after reviewing 
the relevant research literature on indirect costs associated with stroke between 
years 1990-2012: “…indirect costs account for a significant portion of the 
economic burden of stroke, and there is a pressing need to develop proper 
approaches to analyse these costs and to make better use of relevant data 
sources for such studies or establish new ones.” (p. 1753). 
Possible sources for productivity-related information that is not limited to 
employment are income redistribution programs. In many countries, 
individuals outside of the workforce receive one or more forms of income 
supplements, such as disability, sick leave, or unemployment benefits. When 
stroke-related, these income supplements further raise the negative economic 
impact of stroke by adding to the societal cost beyond the productivity losses 
caused solely by the inability to work. However, unlike the inability to work, 
stroke-related income supplements are not restricted to the employed 
subpopulation of patients – both employed and those outside the workforce 
may receive them. As illness-based income supplements are always based on 
disability, they may capture productivity-related variation. Therefore, income 
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supplement data can provide a complementary and less well-understood 
perspective on stroke-related productivity losses.  
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2 Aims of the study 
The purpose of this thesis was to assess the role of cognitive impairment in 
stroke-related productivity losses in a working-aged sample of patients suffering 
their first-ever ischaemic stroke. 
In the first part (Study I), the relationship between post-stroke cognitive 
impairments and other neurological impairments was assessed. Specifically, the 
aim of the first study was to describe the relationship between total National 
Institutes of Health Stroke Scale (NIHSS) (Brott et al., 1989) scores and 
cognitive impairments following stroke. Based on previous studies of neglect 
and aphasia (Croquelois, Wintermark, Reichhart, Meuli, & Bogousslavsky, 
2003; Hillis, Wityk, Barker, Ulatowski, & Jacobs, 2003), it was hypothesized 
that the NIHSS would be insensitive to other domain-specific cognitive 
impairments as well. However, the lowest total NIHSS scores were hypothesized 
to relate to good cognitive outcomes on a global level of cognitive function. 
In the second sub study (Study II), the role of cognitive impairments in the 
vocational outcome of the patients was examined, acknowledging the 
multifactorial nature of post-stroke return to work. The aim was to investigate 
how the severity of stroke, defined as the number of cognitive impairments 
within the first weeks after a first-ever ischaemic stroke, predicts the inability to 
return to employment within the six-month follow-up. The analysis was 
adjusted for demographic, vocational and clinical predictors and mood state. 
Given that gross cognitive impairments are known to predict return-to-work, it 
was hypothesised that a more sensitive assessment of cognitive impairments 
would enhance these predictions. 
Finally, in the third sub study (Study III), a novel method is introduced to 
examine productivity-related variation in a stroke cohort. In this study, registry 
data on stroke-related income supplement use was combined to the clinical 
patient data in order to trace stroke-related productivity changes of the entire 
cohort irrespective the premorbid vocational status of the patients. Given the 
relevance of cognitive impairments to the vocational outcome of stroke, it was 
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hypothesized that the predictors of income supplement use would be 
multifactorial and would emphasize the importance of the cognitive 
impairments.  
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3 Methods 
3.1 Design 
A prospective cohort study design was used. Eligible stroke patients were 
recruited during their acute care from the neurological acute care units and 
followed up periodically until two years after stroke. The patients underwent 
repeated neuropsychological assessments in order to describe their cognitive 
sequelae that was analysed in relation to demographic, clinical and vocational 
information on the patients. Cognitive impairments were defined based on the 
performance of a healthy demographic control group. 
3.2 Setting 
The data were collected consecutively in two Finnish hospitals: Helsinki 
University Central Hospital, Helsinki and Lapland Central Hospital, Rovaniemi. 
Recruitment started in April 2007 and finished in October 2009. All patients in 
this cohort were treated according to the institutional guidelines for stroke care. 
Demographics, clinical and baseline neuropsychological data were collected 
within the first weeks after the stroke, typically during the acute care, whilst the 
follow-up neuropsychological data and vocational data were gathered and 
complemented during follow-up visits. The follow-up visits took place three 
months, six months, one year (partial sample only) and two years after the 
stroke. In this subset of studies, baseline, six-month and two-year follow-up 
data was utilized. Complementary registry data on patients’ income 
supplements were retrieved from the Finnish Social Insurance Institution (Kela) 
and the Finnish Centre for Pensions (ETK) databases. The Ethics Committee of 
Helsinki University Central Hospital approved the study and the consent 
procedure, and all participants provided signed informed consent for clinical 
data acquisition. Informed consents for registry data acquisition were requested 
separately, and registry data were retrieved only for patients who provided 
separate signed informed consent for registry data acquisition. 
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3.3 Participants 
The participants were enrolled from a consecutive sample of all eligible patients 
who were admitted to the clinics. The inclusion criteria were a first-ever 
diagnosed supratentorial ischaemic stroke in native Finnish-speaking patients 
between the ages of 18 and 65 years. Based on clinical history and patient 
reports, patients were excluded if they had neurological or psychiatric history or 
comorbidity potentially promoting cognitive impairments.  
A control group, which consisted of 50 healthy subjects with similar 
demographic characteristics who were eligible based on all of the 
inclusion/exclusion criteria except for the stroke, was also assessed according to 
an identical written study protocol as the patients. The controls were recruited 
from the spouses, siblings and friends of the patients. The controls were 
assessed twice, with a three-month interval between the assessments. 
3.4 Demographic and clinical measures 
The sexes and ages (years) of the study participants were compiled from the 
participants' medical records. The educational status (years of education) was 
obtained from clinical interviews.  
The data on major vascular risk factors included atrial fibrillation, diabetes, 
hypercholesterolaemia, hypertension, overweight (Body Mass Index > 25) and 
smoking, and were collected from the medical records and clinical interviews at 
the time of the baseline neuropsychological assessment. The accumulation sum 
score of the vascular risk factors (0-6) was used in the analyses.  
An experienced stroke neurologist visually evaluated lesion location and size 
of the infarction were from computerized tomography (CT) or magnetic 
resonance imaging (MRI) routinely obtained in the course of standard clinical 
care. The locations were categorised as frontal, parietal, temporal, occipital, 
basal ganglia, multiple with more than one location, or non-visible. The infarct 
size was categorised using a modified version of Paciaroni et al. (2008) as small 
(< 1.5 cm), medium (1.5 - 4.0 cm) or large (> 4.0 cm). Incident silent infarcts 
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and leukoaraiosis were binary encoded. The pathophysiological aetiologies of 
the infarcts were categorised according to the Trial of ORG 10172 in Acute 
Stroke Treatment (TOAST) classification scheme (Adams et al., 1993).  
NIHSS (Brott et al., 1989) and Glasgow Coma Scale (GCS) (Teasdale & 
Jennett, 1974) total sum scores were recorded upon hospital admission and 
upon discharge from the acute care unit. In addition, the functional 
independence was evaluated using the Barthel Index (Mahoney & Barthel, 1965) 
upon the baseline neuropsychological assessment. 
3.5 Cognitive data 
Cognitive data from both the patients and the control subjects were gathered at 
the hospital facilities using neuropsychological assessments administered by 
clinical neuropsychologists following a written study protocol. Baseline 
neuropsychological assessments of the patients were completed within the first 
weeks of their strokes, after the treating neurologist had determined that each 
patient was ready to be discharged from the acute care unit. The timing of the 
baseline assessments was chosen to minimize bias in the neuropsychological 
data caused by fluctuating acute conditions such as delirium or fatigue. 
Neuropsychological assessments included measures of seven cognitive 
domains: executive functions, psychomotor speed, episodic memory, working 
memory, language, visual spatial and constructional skills, and motor skills. 
Each cognitive domain was measured with three separate tests as follows. 
Executive functions were measured with the time to complete Trail Making Test 
Part B (Poutiainen, Kalska, Laasonen, Närhi, & Räsänen, 2010; Reitan, 1958), 
the number of words within one minute in the phonemic fluency task (Lezak, 
Howieson, Bigler, & Tranel, 2012) and the number of correct responses in the 
Go/no-go task (Dubois, Slachevsky, Litvan, & Pillon, 2000). Psychomotor speed 
was measured with the time to complete the Trail Making Test Part A 
(Poutiainen et al., 2010; Reitan, 1958), time per correct response in the copying 
tasks (Carlesimo, Fadda, & Caltagirone, 1993; Lezak et al., 2012) and time per 
correct response in the modified 12-item Token Test (De Renzi & Faglioni, 1978) 
with the large tokens only. Episodic memory was measured with a sum score of 
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immediate and delayed recall in the Wechsler Memory Scale Revised Logical 
Memory I and II (Wechsler, 1987), the sum of correct responses in learning a 
series of 10 unrelated words (Christensen, 1979) with an added delayed recall 
score and sum score of a shortened and modified Benton Visual Retention Test 
(Benton, 1974) (five odd numbered figures of Part C) with added delayed recall 
and delayed recognition scores. Working memory was measured with the Digit 
Span subtest of the Wechsler Adult Intelligence Scale, Third Edition (Wechsler, 
1997), the number of correct responses in the homogeneous interference task 
(Christensen, 1979) and the number of correct responses in the heterogeneous 
interference task (Christensen, 1979). Language was measured with the sum of 
correct responses in the modified 12-item Token Test (De Renzi & Faglioni, 
1978) with the large tokens only, a shortened 31-item Visual Naming task score 
from the Assessment of Aphasia and Related Disorders (the early version of the 
Boston Diagnostic Aphasia Examination) (Laine, Niemi, Koivuselkä-Sallinen, & 
Tuomainen, 1997) and the number of correctly repeated words in the repetition 
of a long sentence with 11 words (Christensen, 1979). Visual spatial and 
construction skills were measured with the number of correct figures in copying 
of 4 geometric figures (Lezak et al., 2012) scored according to Carlesimo et al. 
(1993), the number of correct responses in drawing clock arms into 10 empty 
clock frames according to a digit model (Adunsky, Fleissig, Levenkrohn, Arad, & 
Noy, 2002; Lezak et al., 2012) and the visuospatial searching task (Vilkki, 1989). 
The visuospatial searching task is a variant from commonly used paper and 
pencil tests used to detect hemispatial neglect. In the task, the subject has a 
paper sheet full of drawn straight lines with different orientations, and a marked 
reference line in the middle of the paper. The subject is instructed to mark all 
the lines that have specifically the same orientation with the reference line as 
quickly and errorless as possible. After a practice phase, the task is repeated 
four times each with differing line orientations. Here, the task was scored as the 
sum of correct responses across the four sheets. Motor skills were measured 
with the bimanual hand movements task (Christensen, 1979), the fist-palm-
edge task (Christensen, 1979) and finger tapping test (Lezak et al., 2012). In the 
finger tapping test, the subject is instructed to tap a tapping device with the 
index finger as many times as possible within a ten second frame. The task is 
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first practiced and then repeated four times alternating left and right hands and 
scored as a sum of averaged left and right hand tapping results.  
Internal consistency (Cronbach α) of the cognitive domains calculated among 
the total patient group ranged from α = .72 (psychomotor speed) to α = .91 
(language). 
Post-stroke cognitive impairments were defined mimicking clinical decision-
making, where a repeated pattern of errors is valued clinically relevant. This 
requirement for multiple within-domain failures when defining cognitive 
impairments was used to enhance the specificity of the cognitive impairments 
across a range of situational factors. Specifically, a single test score was 
considered deficient if a patient scored below the 10th percentile for that test 
compared with the performance of the control group. If at least two test scores 
within the same cognitive domain were deficient, a cognitive impairment was 
assumed to exist. 
To describe a global, cross-domain severity of cognitive impairments, the 
number of cognitive impairments for each patient was counted. To avoid bias 
due to learning, patient follow-up data were compared with control follow-up 
data.  
3.6 Mood state, apathy and fatigue 
Mood state was evaluated as part of neuropsychological assessments with a 
modified Profile of Mood States (POMS; McNair & Lorr, 1964) questionnaire 
covering questions on mood, apathy and fatigue at the baseline evaluation with 
a 10-item version, and at follow-ups with a 38-item version. Total symptom sum 
scores were used in the analyses to control for the effect of altered mood state, 
apathy and fatigue to the cognitive performance. In the analyses, the 90th 
percentile level of the control group’s symptom sum score was used as the cut-
off for an impaired mood state. 
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3.7 Vocational data 
The vocational status and type of work were collected in a clinical interview as a 
part of the baseline neuropsychological assessment. At follow-up visits, the 
patients’ vocational statuses were recollected with a questionnaire modified 
from that of Sheehan et al. (1996). 
Post hoc, the vocational statuses were crosschecked against the registry data, 
as described in detail in the next section (3.8) on income supplement use. The 
inability to return to work was defined as not returning to paid employment 
outside the house, either full- or part-time. If a patient was on sick leave or 
disability pension at the six-month follow-up, the diagnoses in the related 
medical certificate were verified to assure the sick leave or pension in question 
actually was caused by the stroke and not any other disease or medical 
condition.  
The type of work was classified as managerial employee, clerical employee, 
employee, entrepreneur or student. A managerial employee refers to 
occupations typically requiring an academic degree, often but not always a 
managerial position with several subordinates, for instance, medical doctors 
and chief executive officers. A clerical employee designates occupations that 
require a vocational degree below the academic degree, including many types of 
office jobs, such as secretary and bookkeeper. An employee indicated manual 
labour, for example, construction worker and housekeeper. An entrepreneur 
designates practitioners, freelancers, professional workers and self-employed 
persons. A student refers to full-time students. 
3.8 Income supplements use 
Income supplement use data were primarily based on registry data acquired 
from the Finnish Social Insurance Institution (Kela) and the Finnish Centre for 
Pensions (ETK). Additional data were collected using a questionnaire modified 
from that of Sheehan et al. (1996), which was completed by the patients during 
their neuropsychological assessments. 
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The registry data covered time from the dates of the patients’ strokes till 
three years after the strokes. The registry data included timely information 
about following income supplements provided in Finland at the time of the 
study: sickness allowances, rehabilitation allowances, disability pensions, 
earning-related pensions, national pensions, guarantee pensions, disability 
allowances, care allowances for pensioners, basic unemployment allowances, 
and labour market subsidies.  
The registry data did not include information on earnings-related 
unemployment allowances, study grants, general housing allowances, housing 
allowances for pensioners, housing supplements for students, housing 
assistance for conscripts, pensions paid from abroad ; for this information, 
questionnaire data was applied (excluding all housing benefits). Any score 
above zero in the stroke-related allowance-use variable refers to the time (in 
months) during which a patient received one or more benefits granted 
specifically on the basis of the stroke diagnosis (possible alternatives are 
sickness allowance, rehabilitation allowance, disability pension, disability 
allowance, or care allowance) within the three-year period after the stroke. 
The aim was to measure the specific impact of stroke on the use of income 
supplements and to avoid any bias introduced by payments for other reasons. 
Therefore, when calculating the stroke-related time of income supplement use, 
any payments that a patient had been receiving before the stroke were removed 
from consideration. For example, if a patient was receiving an age-related 
pension or disability benefits at the time of stroke and continued to receive the 
same benefits after the stroke, then the patient’s stroke-related income 
supplement use was encoded as zero. If a patient was receiving stroke-related 
disability benefits after the stroke but reached retirement pension age during 
the three-year follow-up period, then only the stroke-related income 
supplements received before the age-related pension benefits began were 
encoded as stroke-related income supplement use.  
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3.9 Statistical analyses 
The statistical analyses were computed with the IBM SPSS Statistics Version 
20.0, 21.0 or 22.0 (International Business Machines Corporation, Armonk, New 
York, USA).  
All neuropsychological tests were administered to all participants, and test 
failures (e.g., due to severe aphasia or neglect) were scored as zero points or the 
maximum time. A total of ten cells with missing data in the data matrix, found 
within six different neuropsychological test scores of the patients, were imputed 
using the patient group means of the variables. Profile of Mood States data was 
missing on 11 patients. Whenever possible, missing registry-based income 
supplement data were crosschecked with the patients’ questionnaire data and 
then imputed accordingly. 
Univariate comparisons between the patients and controls, the dropout 
analysis, and associations between independent and dependent variables were 
calculated using t-tests, U-tests, χ2-statistics, Pearson or Spearman correlations, 
or one-way ANOVA depending on variable distributions. In Spearman 
correlations used in Study I, cognitive impairments refer to the numbers of 
defective within-domain test performances (0–3) for each of the seven cognitive 
domains. 
Multivariate analyses were performed with logistic regression models (Study 
I and II) and survival (Cox) models (Study III). In the comparison of clinical 
and cognitive severity of stroke (Study I), enter-method binary logistic 
regression models adjusted for gender, age and education (years) were 
calculated for those cognitive domains that had a significant correlation with 
NIHSS scores. In addition, the total number of cognitive impairments (zero, 
one, two or at least three) and the presence of at least one cognitive impairment 
were also calculated to characterize global, cross-domain cognitive dysfunction. 
When assessing the role cognitive impairments in stroke patients’ inability to 
return to work (Study II), those predictors with a significant univariate 
association with return-to-work were chosen for the enter-method binary 
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logistic regression model comparing the significant predictors of the inability to 
return to work. 
In the analysis of stroke-related income-supplement use (Study III), the 
predictors that had significant univariate associations with the use of stroke-
related income supplements were selected as the covariates for subsequent 
multivariate survival (Cox) models using the enter method. The duration of the 
use of stroke-related income supplements, in months, was set as the time 
variable. Three separate models were built, each using one of the 
neuropsychological data sets (collected at baseline, six months, and two years 
after the stroke).  
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4 Results 
4.1 Sample characteristics 
Figure 1 presents the sample acquisition as a flow diagram. During data 
collection, 38 patients refused to participate, 19 were lost due to logistic reasons 
such as quick discharges or hospital transfers, and 6 severely injured patients 
were excluded because they could not complete the neuropsychological 
assessments. A total of 230 patients initially participated in the study, of which 
186 (80.9%) were treated and assessed in Helsinki University Central Hospital, 
and 44 (19.1%) in Lapland Central Hospital. All together, 15 neuropsychologists 
participated in the data collection procedure. Among the total patient group, 197 
patients remained in the study at the six-month follow-up, and 166 patients 
remained at the two-year follow-up. The 33 patients who were lost to the six-
month follow-up were less educated (mean [M] = 11.1 years, standard deviation 
[SD] = 2.80 versus M = 12.1, SD = 2.67, t228 = 22.02, p = .045) and more likely 
to have leukoaraiosis than were the patients who continued to participate in the 
study (39.4% of the patients lost to follow-up versus 22.4% of the ongoing study 
participants; χ21 = 4.34, p = .037). The patients who were lost at the six-month 
follow-up also had a higher mean rank NIHSS score at the time of hospital 
admission (median = 3, range = 0–24 versus median = 3, range = 0–17, U = 
2505.5, p = .033) and a higher number of baseline cognitive impairments than 
those of the patients who participated in the six-month follow-up (median = 2, 
range = 0–7 versus median = 1, range = 0–7, U = 2488.5, p = .022). Comparing 
the participants in the two-year follow-up with those 31 lost to follow-up, more 
frequent cognitive impairments were observed in the dropout group than in the 
participants (median = 3, range = 0–7 versus median = 1, range = 0–7, U = 
1526.5, p = .004). No significant differences were found with regard to other 
characteristics, i.e. sex, age, vascular risk factors, aetiology (TOAST), lesion size, 
silent infarcts, NIHSS scores at discharge, functional independence (Barthel 
Index), or mood state, apathy and fatigue (POMS), between the patients lost to 
follow-up and those who participated in the study at each follow-up 
examinations. 
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Figure 1. The numbers of included and excluded patients and of those who left the study at 
each stage.  
The initial cohort with 230 patients included 146 men (63.5 %), had a mean 
age of 54.0 years (SD = 9.82), a mean of 12.0 years of education (SD = 2.71) and 
a median of three (range = 0–6) vascular risk factors. The controls were 
demographically similar to the patient group, but they had fewer vascular risk 
factors (median = 2, range = 0–5, U = 4434.0, p = .009) and reported fewer 
mood state, apathy and fatigue symptoms (POMS median 11.0, range = 0–32 
versus median = 7.5, range = 0–21, U = 2696.0, p < .001). The participants are 
characterized in detail in Table 1. In study III, the full data from 230 patients 
was examined.  
In study I, 223 patients were analysed. The clinical interview of the patients 
covered developmental learning disabilities. Seven patients reported in the 
Eligible but was not recruited                         N = 63
• Refusals                                                     N = 38
• Logistic reasons                                         N = 19
• Too severely injured to complete 
neuropsychological assessment                 N = 6 
Baseline assessment
• Demographic, clinical and cognitive data     N = 230
• Questionnaire data                                       N = 229 Loss to six-month follow-up                            N = 33
• Refusals                                                      N = 14
• Logistic reasons                                          N = 19
Six-month follow-up
• Clinical and cogntiive data                            N = 197
• Questionnaire data                                       N = 207 Loss to two-year follow-up                              N = 31
• Refusals                                                      N = 10
• Logistic reasons                                          N = 15
Two-year follow-up • Deceased                                                    N = 6
• Clinical and cognitive data                            N = 166
• Questionnaire data                                       N = 174
Three-year follow-up on income supplements use
• Registry data                                                 N = 175
• Combined registry and questionnaire data   N = 230
 
 
33 
interview that as a child they had had a learning disability. In study I, the 
specificity of the reported post-stroke cognitive impairments was evaluated to 
be so important to the credibility of the results that it was decided these seven 
patients would be excluded based on their subjective reports of learning 
disability. Eventually, excluding these patients remained more theoretically 
than empirically motivated, as these seven patients did not significantly differ 
from others with regard to sex, age, education, number of vascular risk factors, 
aetiology, lesion size, NIHSS or GCS at either measurements, or number of 
cognitive deficits at any of the assessments.  
Regarding characteristics of Study II, the criterion of working outside the 
house prior to the stroke was fulfilled in 161 of the 230 patients, and of those, 
140 patients (60.9 % of the 230 patients) completed the follow-up assessment 
and were thus analysed. 
4.2 Clinical characteristics 
The average (M) duration of hospital stays in the full cohort of 230 patients was 
9.04 days (SD = 5.12). At hospital admission, patients scored a median of three 
(range = 0–24) in NIHSS and 90.0 % (N = 207) of the patients had gross 
neurological findings with a NIHSS score above zero. At the discharge from the 
acute care unit, 68.7 % (N = 158) patients still had a NIHSS score of one or more 
(median = 1, range = 0–16). GCS median was 15 both at hospital admission 
(range = 10–15) and at discharge from the acute care unit (range = 2–15). The 
cohort also recovered well functionally as the Barthel Index median was 100 
(range = 25–100) at the time of the baseline neuropsychological assessment. 
Large-artery atherosclerosis was the dominant pathophysiological aetiology (N 
= 58, 25.2 %) of the strokes. Small-artery occlusion accounted for 23.5 % of the 
strokes (N = 54) and cardioembolism 21.3 % (N = 49), respectively. 
Hypertension (N = 87, 62.1%) and hypercholesterolaemia (N = 79, 56.4%) were 
the most frequent vascular risk factors of the patients.  
Typical brain lesions of the patients were small (< 1.5 cm, N = 97, 42.2 %) or 
intermediate (1.5-4.0 cm, N = 55, 23.9 %) in size while 13.9 % of the patients (N 
= 32) had a stroke with the largest diameter of over 4.0 cm. In 20.0 % of the 
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patients (N = 46) the diagnoses of ischaemic stroke were based on clinical 
features without visible brain imaging findings. Imaging revealed a silent infarct 
in 24.3 % (N = 56) and leukoaraiosis in 24.8 % (N = 57) of the patients.  
By the end of the two-year follow-up period, recurrent stroke was identified 
in 7.0 % (N = 16) of the patients and 2.6 % (N = 6) had deceased.  
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Table 1. Characteristics of 230 stroke patients and 50 control participants. 
Characteristic Patients Controls p 
Men (N) 146 (63.5 %) 31 (62.0 %) .844 
Age (mean [M]) 54.0 (SD = 9.8) 54.3 (SD = 9.0) .850 
Education (M) 12.0 (SD = 2.7) 12.4 (SD = 2.9) .396 
Vascular risk factors    
   Atrial fibrillation (N) 25 (10.9) 1 (2.0) n/a 
   Diabetes    
       Type I (N) 5 (2.3 %) 0 (0.0 %) n/a 
       Type II (N) 25 (10.9 %) 3 (6.0 %) n/a 
   Hypercholesterolemia (N) 139 (60.4 %) 29 (58.0 %) .750 
   Hypertension (N) 154 (67.0 %) 29 (58.0 %) .228 
   Overweight (N) 154 (67.0 %) 35 (70 %) .677 
   Smoking (N) 88 (38.3 %) 9 (18.0 %) .006 
Number of vascular risk factors (N) 3 (range = 0–6) 2 (range = 0–5) .009 
Aetiology (TOASTa)    
   Large artery atherosclerosis (N) 58 (25.2 %)   
   Cardioembolism (N) 49 (21.3 %)   
   Small-artery occlusion (N) 54 (23.5 %)   
   Other, determined (N) 21 (9.1 %)   
   Undetermined (N) 48 (20.9 %)   
Lesion sizeb    
   < 1.5 cm (N) 97 (42.2 %)   
   1.5-4.0 cm (N) 55 (23.9 %)   
   > 4.0 cm (N) 32 (13.9 %)   
   Lesion not visible (N) 46 (20.0 %)   
Silent infarct (N) 56 (24.3 %)   
Leukoaraiosis (N) 57 (24.8 %)   
Stroke severity (NIHSSc)    
   Hospital admission (median) 3 (range = 0–24)   
   Discharge (median) 1 (range = 0–16)   
Functional independence (Barthel Index median) 100 (range = 25–100)   
Mood state, apathy and fatigue (POMS)d    
   Baseline (N = 217, median) 12 (range = 1–32) 7.5 (range = 0–21) < .001 
   Six-month follow-up (N = 187, median) 35 (range = 0–149) 25.5 (range = 0–89)e .032 
   Two-year follow-up (N = 161, median) 35 (range = 2–136)   
aTrial of ORG 10172 in Acute Stroke Treatment classification scheme; bLesion size was visually 
evaluated from computerized tomography (CT) or magnetic resonance imaging (MRI) routinely 
obtained in the course of standard clinical care. The infarct size was categorised using a 
modified version of Paciaroni et al. (2008); cNational Institutes of Health Stroke Scale; dProfile 
of Mood States questionnaire, at baseline a shortened 10-item version, at follow-ups the full 30-
item version was used; eControls were re-examined after three months.  
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4.3 Cognitive impairments, mood state, apathy and fatigue 
The baseline, six-month follow-up and two-year follow-up neuropsychological 
assessments were conducted an average of eight days (SD = 4.36), 186 days (SD 
= 14.01), and 745 days (SD = 58.96) after the strokes, respectively. The duration 
of the assessments was approximately 1.5-2.5 hours depending on the condition 
and functioning of the patients. At the baseline assessment, 56.5 % of the 
patients (130/230 patients) exhibited cognitive impairments. At six months, the 
proportion of patients with cognitive impairments had significantly fallen to 
46.7 % (92/197 patients, χ21 =51.49, p < .001). At the two-year follow-up, the 
proportion of patients with cognitive impairments was further reduced to 44.0 
% (73/166 patients), but this reduction was not statistically significant (χ21 = 
.50, p = .482). Psychomotor slowness and executive dysfunction were the most 
prevalent cognitive impairments throughout the two-year follow-up period. 
Figure 2 presents the prevalences of cognitive impairments from the baseline 
through the follow-up. Mood state, apathy and fatigue data were available for 
217 patients at baseline, 187 patients at the six-month follow-up and 161 
patients at the two-year follow-up. As a group, the patients expectedly reported 
more mood state, apathy and fatigue symptoms than the controls (baseline: 
median = 12.0, range = 1–32 versus median = 7.5, range = 0–21, U = 2969.0, p 
< .001; follow-up [patients: six-month; controls: three-month]: median = 35.0, 
range = 0–149 versus median = 25.5, range = 0–89, U = 3423.0, p = .032). 
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Figure 2. The prevalence of cognitive impairments at the baseline assessment completed 
within the first weeks after stroke (N = 230), at six-month follow-up (N = 197) and at two-year 
follow-up (N = 166). Each cognitive domain was measured with three separate tests. A single 
test score was considered deficient if a patient scored below the 10th percentile compared with 
the performance of the control group. If at least two test scores within the same cognitive 
domain were deficient, a cognitive impairment was assumed to exist. 
4.4 Vocational characteristics 
Vocational characteristics refer here to Study II with a subset of 140 patients 
both working full-time outside the house before the stroke and participating in 
the six-month follow-up. Of those, employees were the biggest occupational 
subgroup (N = 61, 43.6 %) followed by managerial employees (N = 37, 26.4 %), 
clerical employees (N = 26, 18.6 %), entrepreneurs (N = 11, 7.9%) and students 
(N = 5, 3.6 %). By six months after the stroke, 41.4 % of the patients (N = 58) 
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had succeeded in returning to work. Regarding the remaining 58.6 % of the 
patients (N = 82), 46.4 % (N = 65) were still on sick leave, and 2.9 % (N = 4) 
were on a disability pension, 5.0 % (N = 7) were unemployed and 4.3 % (N = 6) 
of the patients had retired. Figure 3 presents the vocational characteristics of 
these 140 patients who were employed and working at the time of their stroke, 
stratified by the type of work.  
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Figure 3. The six-month vocational outcome stratified by the type of work in 140 stroke 
patients who were employed at the time of first-ever ischaemic stroke. 
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4.5 Stroke-related income supplements use 
A total of 175 patients granted permission for registry searches of their income 
supplement use. The patients with available registry data had higher levels of 
education (M = 12.2, SD = 2.66 versus M = 11.2, SD = 2.72, t228 = -2.47, p = 
.014), lower NIHSS scores at hospital admission (median = 2, range = 0–20 
versus median = 4, range = 0–24, U = 3671.0, p = .007) and longer duration of 
stroke-related income supplements use (M = 8.0, SD = 12.7 versus M = 12.6, SD 
= 15.3, t107.9 = -2.24, p = .027) than those of the patients without registry data. 
Complementary questionnaire data on income supplements were initially 
available for 229 patients; these data were available for 207 patients at the six-
month follow-up and 174 patients at the two-year follow-up. By combining the 
registry data with the questionnaire data and assuming that permanent income 
supplements would continue for up to three years among the 55 patients with 
missing registry data, the stroke-related income supplements could be 
calculated over three years after stroke for all 230 patients.  
At the time of the stroke, 72.2 % of the patients (N = 166/230 patients) were 
not receiving any income supplements, whereas three years later, only 29.6 % 
(N = 68/230 patients) were not receiving any form of income supplement. 
Stroke specifically caused a mean of 11.5 months (SD = 14.82, range = 0–36) of 
additional income supplement use among the patients, while 69.1 % of the 
patients (N = 159/230 patients) received income supplements due to their 
strokes. These payments continued until three months in 54.8 % (N = 126 / 230 
patients) and up to six months in 39.1 % of the patients (N = 90/230 patients). 
One year after the stroke 31.3 % of the patients (N = 72/230 patients), at two 
years 25.7 % (N = 59/230 patients), and at three years 23.5 % (N = 54/230 
patients), still received stroke-related income supplements. Figure 4 presents 
the use of income supplements in the cohort at baseline and at the three-year 
follow-up.  
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Figure 4. The use of income supplements in 230 stroke patients at the time of a first-ever 
ischaemic stroke and at the three-year follow-up. 
4.6 Comparison of clinical and cognitive severity of stroke 
All the correlations between the NIHSS admittance scores and impairments in 
all seven cognitive domains reached statistical significance (p < .01) and ranged 
from r = .18 (episodic memory) to r = .40 (motor skills). The NIHSS discharge 
score correlations with cognitive impairments equally reached significance (p < 
.01) for all seven cognitive domains but the correlations were systematically 
stronger, with correlations ranging from r = .34 (working memory) to r = .44 
(motor skills). 
Separate logistic regression models adjusted for gender, age and education 
were computed to predict domain-specific cognitive impairments within the 
first weeks after the stroke with NIHSS scores upon admittance and discharge. 
Adjusted for demographics, the NIHSS discharge score stably predicted 
cognitive impairments with odds ratios (OR) ranging from OR = 1.37 (95 % CI = 
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1.18–1.60) for episodic memory to OR = 1.87 (95 % CI = 1.52–2.29) for motor 
skills. The NIHSS score at discharge was systematically more effective in 
predicting impairments than the admittance score. The predictive models had 
rather high specificities, which ranged from 89.5–97.7 %, but the sensitivities 
were as low as 11.6–47.9 %. Approximately two patients out of five with a 
NIHSS score of zero (41.0 %) had baseline cognitive impairments, as did over 
half of the patients (54.0 %) with a score of one. Among patients with NIHSS 
scores of two or three the prevalence of baseline cognitive impairments 
increased linearly, and all patients in this functionally well-recovered working-
age cohort who had NIHSS scores of four or higher exhibited cognitive 
impairments. The prevalence of all seven domain-specific cognitive 
impairments except for the motor skills lowered significantly (p < .05) from the 
baseline to the follow-up, yet the common relationship between cognitive 
impairments and even the lowest NIHSS scores persisted at the six-month 
follow-up. Figure 5 presents the accumulation of cognitive impairments 
stratified to the NIHSS scores. 
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Figure 5. Prevalence of cognitive impairments at baseline and at the six-month follow-up 
stratified into the accumulation of neurological impairments as indicated by NIH Stroke Scale 
(NIHSS) scores. 
To control for confounding factors, those patients with cognitive impairments 
(N = 136 / 223) were compared to cognitively intact patients (N = 87 / 223). The 
occurrence of cognitive impairments was not accountable for the accumulation 
of six principal vascular risk factors (median = 3, range = 0–6 versus median = 
3, range = 0-5, U = 4919.5, p = .071), silent infarcts (27.2 % [N = 37] versus 20.7 
% [N = 18], χ21 =1.11, p = .291), leukoaraiosis (27.2 % [N = 37] versus 23.0 % [N 
= 20], χ21 = .73, p = .393), nor mood state (median = 13, range = 1–31 versus 
median = 11, range = 2–32, U = 4547.5, p = .052). To further test the role of 
these possibly confounding factors the comparisons were rerun for those 135 
patients with the lowest NIHSS scores of 0-1 at discharge from the acute care 
unit. This repeat analysis did not alter the results as none of the factors 
saturated significantly in the subgroups of 64 cognitively impaired and 71 intact 
%
 o
f p
at
ie
nt
s 
w
ith
 a
t l
ea
st
 o
ne
 c
og
ni
tiv
e 
im
pa
irm
en
t
0
20
40
60
80
100
NIHSS = 0 NIHSS = 1 NIHSS = 2 NIHSS = 3 NIHSS ≥ 4
85
46
62
36
32
100
81
68
54
41
Baseline Six-month follow-up
NIH Stroke Scale (NIHSS) score at discharge
 
 
44 
patients (vascular risk factors: median = 3, range = 0-6 versus median = 3, 
range = 0–5, U = 1871.0, p = .123; silent infarcts: 31.3 % [N = 20] versus 22.5 % 
[N = 16], χ21 = 1.67, p = .196; leukoaraiosis: 32.8 % [N = 21] versus 23.9 % [N = 
17], χ21 = 1.20, p = .274; mood state, apathy and fatigue: median = 13, range = 1–
31 versus median = 11, range = 2–32, U = 1863.0, p = .156). 
4.7 Model of return to work after stroke 
The model predicting return to work after stroke was built on the basis of 
significant one-way associations between predictors and return-to-work 
outcome. Age (t138 = -3.25, p = .001) and education (t138 = 2.15, p = .033), but 
not sex (χ21 = .23, p = .628), were related to the inability to return to work. The 
type of work did not quite reach significance (χ24 = 8.674, p = .070), but as an 
exception was nevertheless included in the final model because of the variable’s 
general relevance to the study. 
The NIHSS (admittance: U = 1475.0, p < .001; discharge: U = 1155.5, p < 
.001) and GCS scores (admittance: U = 1874.0, p = .003; discharge: U = 2088.0, 
p = .006) and TOAST (χ24 = 12.20, p = .016) were associated with the inability 
to return to work and included in the final model. In total, 72.2 % (N = 26 / 36) 
of the patients in the large artery atherosclerosis group, 71.0 % (N = 22 / 31) in 
the cardioembolism group and 66.7 % (N = 10 / 15) in the other determined 
cause group were unable to return to work. Regarding patients with small-artery 
occlusion or undetermined cause, 41.4 % (N = 12 / 29) did not return to work. 
The size of the lesion (U = 11.7, p = .008) as the only significant radiological 
factor and Barthel Index (U = 1607.0, p < .001) also had a significant one-way 
association with the outcome and were included in the final model. 
All baseline impairments across seven cognitive domains significantly 
associated with the outcome (p < .001 except for working memory p = .002). At 
the six-month follow-up, all but the visual spatial and constructional skills (p = 
.413) had a significant (p < .01) one-way association with the inability to return 
to work (except for motor skills p = .016). In contrast, mood state, apathy and 
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fatigue (POMS) were not associated with the outcome neither at baseline (χ21 = 
1.40, p = .237) nor at the six-month follow-up (χ21 = 1.68, p = .195). 
In order to eliminate excess multicollinearity in the final model, the predictor 
variable list was modified as follows. For the NIHSS and GCS, only the 
measurement with a stronger univariate association (NIHSS: discharge, GCS: 
admittance) was selected for the final model. The baseline cognitive data were 
included in the model as the number of cognitive impairments. The cognitive 
follow-up data were included in the model as the persistence of cognitive 
impairments.  
The final model is presented in Table 2. In the model, only the number of 
baseline cognitive impairments (OR = 2.25, 95 % CI = 1.29–3.92, p = .004) was 
a significant predictor. Compared with a patient with no baseline cognitive 
impairments, each cognitive impairment a patient had more than doubled the 
risk of the inability to return to work. The persistence of baseline cognitive 
impairments was the only other predictor that came close to reaching the level 
of significance (OR = 2.72, 95 % CI = .94–7.86, p = .064). 
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Table 2. Logistic regression model of the inability to return to work six months after a first-
ever ischaemic stroke. 
Predictor Wald (df) p Odds ratio 
95% CI 
Lower Upper 
Number of cognitive impairmentsa 8.24 (1) .004 2.25 1.29 3.92 
Persistence of impairmentsb 3.42 (1) .064 2.72 .94 7.86 
Age 1.20 (1) .274 1.04 .97 1.11 
Education years .00 (1) .993 1.00 .79 1.27 
Type of workc 1.14 (4) .888    
   Clerical employee .44 (1) .507 .57 .11 3.00 
   Employee .03 (1) .871 .89 .20 3.85 
   Entrepreneur .50 (1) .481 .48 .06 3.65 
   Student .30 (1) .582 .40 .02 10.29 
Stroke severity (NIHSS)d 2.56 (1) .110 1.53 .91 2.58 
Stroke severity (GCS)e 1.41 (1) .235 .75 .47 1.20 
Aetiology (TOASTf) 3.12 (4) .537    
   Cardioembolism .18 (1) .676 .74 .18 3.09 
   Small-artery occlusion 1.79 (1) .181 .38 .09 1.56 
   Other determined .15 (1) .701 1.49 .20 11.42 
   Undetermined 1.05 (1) .305 .47 .11 1.98 
Lesion size .01 (1) .943 .98 .55 1.73 
Functional independence (Barthel 
Index)a 2.12 (1) .145 .92 .83 1.03 
Constant 1.99 (1) .158 11747.11   
aBaseline; bPersistence = compared with baseline, no improvement at six-month follow-
up; cManagerial employee = occupations typically requiring an academic degree, clerical 
employee = occupations requiring a vocational degree below the academic degree, 
employee = manual labour, entrepreneur = e.g. practitioners and self-employed 
persons, student = full-time students; dNational Institutes of Health Stroke Scale, 
measured at discharge from the acute care unit; eGlasgow Coma Scale, measured at 
admittance to hospital; fTrial of ORG 10172 in Acute Stroke Treatment (TOAST) 
classification scheme; The inability to return to work is the predicted category; The 
reference category for the type of work is managerial employee; The reference category 
for aetiology is large-artery atherosclerosis. 
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4.8 Models of stroke-related income supplements use 
The predictors of stroke-related income supplements use were chosen for the 
multivariate models based on significant univariate associations, described in 
detail in Table 3. The presence of atrial fibrillation, use of an income 
supplement before experiencing a stroke, NIHSS score at hospital discharge, 
Barthel Index score, lesion size, and mood state, apathy and fatigue at the six-
month and two-year follow-ups, as well as most of the cognitive variables at 
each assessment, were significantly associated with the use of income 
supplements and were thus included in the subsequent multivariate survival 
models. Similarly as when predicting return to work, the number of cognitive 
impairments was chosen to collectively represent the cognitive function data in 
the models to avoid excessive multicollinearity among the predictor variables. 
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Table 3. Univariate predictors of stroke-related income supplement use. 
Predictor Test value p 
Sex t228 = .55 .586 
Age rPearson = .00 .948 
Education rPearson = .01 .883 
Accumulated vascular risk factors rSpearman= .06 .372 
   Atrial fibrillation t43.2 = -2.41 .020 
   Diabetes t228 = -.90 .370 
   Hypertension t160.7 = -1.41 .162 
   Hypercholesterolemia t179.3 = 1.39 .166 
   Overweight t228 = -1.21 .229 
   Smoking t228 = .91 .366 
Income supplement use before stroke t177.4 = 6.69 < .001 
Stroke severity (NIHSSa)   
   Hospital admission rSpearman = .12 .070 
   Discharge rSpearman = .28 < .001 
Functional independence (Barthel Index) rSpearman = -0.24 < .001 
Aetiology (TOASTb) F4 = 1.91 .109 
Lesion   
   Size rSpearman = .25 < .001 
   Location F8 = 1.87 .066 
Vascular degeneration t228 = .31 .755 
Silent infarcts t228 = .43 .665 
Cognitive impairments   
   Baseline   
      Executive function t122.7 = -3.25 .001 
      Psychomotor speed t151.7 = -3.32 .001 
      Episodic memory t83.4 = -3.57 .001 
      Working memory t228 = -1.79 .074 
      Language t68.4 = -3.02 .004 
      Visuospatial and construction skills t103.0 = -3.20 .002 
      Motor skills t83.1 = -3.55 .001 
      Number of cognitive impairments rSpearman = .26 < .001 
   Six-month follow-up   
      Executive function t70.9 = -1.32 .192 
      Psychomotor speed t71.6 = -3.37 .001 
      Episodic memory t39.3 = -2.45 .019 
      Working memory t195 = -3.56 < .001 
      Language t195 = -3.75 < .001 
      Visuospatial and construction skills t22.3 = -1.49 .149 
      Motor skills t51.3 = -2.25 .029 
      Number of cognitive impairments rSpearman =.16 .021 
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Predictor Test value p 
   Two-year follow-up   
      Executive function t46.1 = -1.74 .089 
      Psychomotor speed t49.2 = -3.19 .003 
      Episodic memory t42.6 = -2.13 .039 
      Working memory t164 = -3.33 .001 
      Language t164 = -2.36 .019 
      Visuospatial and construction skills t23.1 = -2.18 .040 
      Motor skills t44.4 = -2.96 .005 
      Number of cognitive impairments rSpearman = .19 .009 
Mood state, apathy and fatigue (POMSc)   
   Baseline rSpearman = .13 .059 
   Six-month follow-up rSpearman = .18 .016 
   Two-year follow-up rSpearman = .17 .033 
aNational Institutes of Health Stroke Scale; bTrial of ORG 10172 in Acute Stroke Treatment 
(TOAST) classification scheme; cProfile of Mood States questionnaire, at baseline a shortened 
10-item version, at follow-ups the full 30-item version was used. 
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Tables 4A-C present the multivariate models of income supplement use, with 
one model corresponding to each set of cognitive data (baseline [Table 4A], six-
month follow-up [Table 4B], and two-year follow-up [Table 4C]). Prior use of 
income supplements undercut the need for additional post-stroke income 
supplementation. Expectedly, prior use of income supplements had a strong 
negative association with the use of stroke-related income supplements in all 
three models. In each model, the presence of atrial fibrillation and number of 
cognitive impairments were the only significant health-related predictors of 
income supplement use. In the first model, which included data from the 
baseline neuropsychological assessment, the presence of atrial fibrillation 
reduced the probability (hazard in survival models) of terminating stroke-
related income supplement use at a given time within the first three years after 
stroke by 43 % (hazard ratio [HR] = .57, 95 % CI = .36-.91, p = .017). With each 
additional cognitive impairment, the probability of terminating income 
supplement use was reduced by 26 % (HR = .77, 95 % CI = .68-.89, p < .001). In 
the second model, which included cognitive impairment data from patients at 
the six-month follow-up, the presence of atrial fibrillation reduced the 
probability of terminating income supplement use by 46 % (HR = .54, 95 % CI = 
.31-.93, p = .027), and each additional cognitive impairment reduced the 
probability by 18 % (HR = .82, 95 % CI = .69-.98, p = .026). In the last model, 
which included cognitive impairment data from the two-year follow-up, the 
presence of atrial fibrillation reduced the probability of terminating income 
supplements by 54 % (HR = .46, 95 % CI = .24-.90, p = .023), with another 19 % 
reduction for each additional cognitive impairment (HR = .81, 95 % CI = .66-
.99, p = .040). 
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Tables 4A-C. Cox models of stroke-related income supplements use during the first three 
years after stroke in a cohort of working-aged stroke survivors (N = 230). Predictor lists are 
based on significant univariate associations with the outcome. 
A. Model with baseline cognitive data 
Predictors Hazard Ratio 95% CI p 
Supplement use before the strokea 3.66 2.56-5.24 < .001 
Atrial fibrillation .57 .36-.91 .017 
Stroke severity (NIHSSb) 1.00 .90-1.10 .954 
Functional independence (Barthel Index) 1.11 1.00-1.03 .064 
Lesion size (largest diameter in CTc / MRId) .87 .73-1.04 .124 
Number of cognitive impairments .77 .68-0.89 < .001 
 
B. Model with six-month follow-up cognitive and mood state, apathy and fatigue data 
Predictors Hazard Ratio 95% CI p 
Supplement use before the strokea 3.39 2.22-5.19 < .001 
Atrial fibrillation .54 .31-.93 .027 
Stroke severity (NIHSSb) .95 .85-1.07 .417 
Functional independence (Barthel Index) 1.02 1.00-1.04 .070 
Lesion size (largest diameter in CTc / MRId) .88 .73-1.08 .228 
Number of cognitive impairments .82 .69-.98 .026 
Mood state, apathy and fatigue (POMSe) 1.00 .99-1.01 .714 
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C. Model with two-year follow-up cognitive and mood state, apathy and fatigue data 
Predictors Hazard Ratio 95% CI p 
Supplement use before the strokea 2.93 1.83-4.68 < .001 
Atrial fibrillation .46 .24-0.90 .023 
Stroke severity (NIHSSb) .92 .81-1.05 .235 
Functional independence (Barthel Index) 1.02 1.00-1.04 .076 
Lesion size (largest diameter in CTc / MRId) .89 .70-1.13 .343 
Number of cognitive impairments .81 .66-.99 .040 
Mood state, apathy and fatigue (POMSe) 1.00 0.99-1.00 0.481 
aSupplement use before the stroke was based on combined registry and questionnaire data and 
included information about age- and disability-based benefits, sick-leave allowances, and 
unemployment funds granted to the patients; bNational Institutes of Health Stroke Scale, 
measured at discharge from acute care; cComputed tomography; dMagnetic resonance imaging; 
eProfile of Mood States questionnaire 
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5 Discussion 
5.1 Key results 
The presented set of studies aimed to clarify the role of cognitive impairments in 
patients’ ability to return to their productive activities after a stroke. More 
specifically, Study I aimed to describe the parallels of post-stroke cognitive 
impairments and clinical severity of stroke, and Study II aimed to model 
predictors of post-stroke vocational outcome. In Study III, a novel method to 
explore post-stroke productivity beyond paid work was introduced by modelling 
the use of stroke-related income supplements. 
In Study I, clinical severity of stroke as detected by NIHSS proved alarmingly 
insensitive to stroke patients’ cognitive impairments, despite the strictly 
conservative definition of cognitive impairments used in the study. Almost half 
of neurologically intact patients appeared to have clinically relevant cognitive 
impairments. Even after controlling for the effects of vascular risk factors, silent 
infarcts, leukoaraiosis and mood state, no NIHSS cut-off scores were found that 
would even tentatively predict intact cognition.  
In Study II, the baseline cognitive severity of stroke reliably and most 
effectively predicted the inability to return to work six months after a stroke, 
taking into account various factors affecting return to work. Six months after the 
stroke, 41 % of the patients had managed to return to their former employment. 
This was the first study to apply a thorough neuropsychological assessment 
together with other relevant health-related and health-unrelated factors to 
model post-stroke return to work. In the model, each cognitive impairment a 
patient exhibited within the first weeks after the stroke more than doubled the 
later risk of inability to work.  
In Study III, stroke-related income supplement use data was modelled as a 
novel, indirect indicator of productivity losses among the whole cohort of 
patients irrespective of premorbid occupational status. Patients received on 
average of 12 months specifically stroke-related income supplements. As key 
results, atrial fibrillation was the most effective health-related, and cognitive 
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impairments the most effective stroke-related predictor of income supplement 
use. The study introduces one of the first attempts to measure stroke patients’ 
productivity-related variation that includes but is not restricted to paid 
employment. 
5.2 Limitations 
The following aspects of the study methodology should be weighed in order to 
interpret and evaluate the results presented here.  
It was attempted to recruit as many participants as possible from a 
consecutive series of patients. Despite efforts, consecutive enrolment failed in 
63 patients, which creates a possibility of bias in the inclusion process. The 
sample size was determined in advance to enable answering the research 
questions. However, the sample size was relatively modest for analysing 
complex multifactorial phenomena, especially for the controls. Furthermore, 
dissimilarity of sample sizes between the patients and the controls weakens the 
representativeness of the control data, although the two groups were similar 
with regard to distributions of sex, age and education.  
This study was able to utilize only brain imaging available in standard clinical 
practice. Diagnosing ischaemic stroke can be based on clinical features even if 
ischemia does appear in acute CT. Only some of the patients without CT 
findings are referred to MRI, as it is not always a prerequisite for adequate 
treatment planning in the acute setting. As a consequence, every fifth patient in 
this study was diagnosed in the absence of imaging findings. This might 
potentially heighten the risk of diagnosing stroke-mimics as strokes and to a 
minor extent exaggerate the good recovery of this working-aged study sample 
compared to the general stroke population. For the main arguments of the 
study, however, regarding the sensitivity and significance of cognitive 
impairments to stroke outcome, the lack of systematic MRI for every patient has 
little effect. 
Neuropsychological patient studies would benefit from accurate data about 
the patients’ premorbid cognitive state. In this study, the issue was addressed 
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with a carefully collected control group and by stressing sufficiently 
conservative and clinically relevant definition of cognitive impairments. These 
remedies certainly do not solve the issue entirely. Without exact data on 
premorbid cognitive performance, the descriptions of post stroke cognitive 
impairments remain estimates, at best. Sources of potential bias are found in 
both ends of the patient group’s cognitive performance: in excessive 
interpretation of weak performance as stroke-related cognitive impairments, 
and in underestimation of stroke-related cognitive impairments in those 
patients with the highest premorbid cognitive capacity.  
The timing of the baseline neuropsychological assessment was balanced to 
minimise the possible effect of changing acute conditions, such as cerebral 
oedema and intracerebral pressure. However, these factors were not explicitly 
controlled for, which can potentially lead to an overestimation of baseline 
cognitive impairments. Considering the precautions taken in the timing of 
baseline neuropsychological assessments, the consistency of neuropsychological 
findings during the entire two-year follow-up, and the predictive power of the 
baseline cognitive impairments, the potential bias caused by these fluctuating 
acute phase conditions seem diminutive. 
An administered but totally failed test was scored as poor performance. This 
decision helped in consecutive patient enrolment and enabled including some 
patients with very severely disabling conditions such as aphasia. However, 
scoring an administered but totally failed test as poor performance potentially 
inflates the risk of incurring a type I error in encoding other cognitive domains 
than the truly impaired ones as defective. For example, if a patient also failed a 
test other than language-related tests because of their aphasia, the patient was 
more likely to also have other domains scored as defective irrespective of 
whether the patient truly had any other cognitive impairments besides aphasia. 
Therefore, the reported prevalence rates of the domain-specific cognitive 
impairments might theoretically be marginally inflated. The prevalences of 
post-stroke cognitive impairments reported here are, however, relatively 
conservative and do not suggest this type of distortion in the results.  
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Patients’ own conceptions of why they have not returned to work would help 
the interpretation of the results in Study II. Unfortunately the question could 
not be fully answered.  
Regarding Study III, 55 patients did not grant permission to retrieve registry 
data on income supplements. Compared to those 175 patients who granted 
access to their registry data, these 55 refusers exhibited lower education levels 
and higher NIHSS scores at hospital admission and they were provided shorter 
periods of income supplements. Potentially, this could indicate a source of 
systematic bias leading to minor inaccuracy in the analysis of income 
supplement data. However, the questionnaire data used to impute missing 
registry data were identical to the registry data for the patients with both 
registry and questionnaire data thus supporting accuracy of the income 
supplement data.  
5.3 Interpretation 
The prevalence of cognitive impairments in the first weeks after stroke is 
found to be above 70 %, and within the first three months 50-90 % (Gottesman 
& Hillis, 2010). Found prevalences depend on the sample, the timing of the 
assessments and the definition of cognitive impairments. In this fairly young 
stroke cohort, cognitive impairments were defined by mimicking clinical 
decision-making, resulting in prevalences of 57 % within the first weeks, 47 % at 
the six-month follow-up, and 44 % at the two-year follow-up. Impairments in 
executive functions and psychomotor speed were the most prevalent cognitive 
impairments from the baseline through follow-up. Rare reports on even longer-
term follow-up suggest these impairments will be enduring (Schaapsmeerders 
et al., 2013).  
These clinically significant cognitive impairments are at risk of being masked 
by otherwise good clinical and functional recovery and remaining unnoticed. In 
Study I, 41 % of clinically intact patients had cognitive impairments that could 
not be accounted for by confounding factors. Recently, Jokinen et al. (2015), 
(see also Wong & Mok, 2015), made essentially the same observation by 
contrasting the prevalence of cognitive impairments in a general stroke cohort 
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with functional outcome measured with the modified Rankin Scale (mRS) (van 
Swieten, Koudstaal, Visser, Schouten, & van Gijn, 1988). Consistent with the 
results of Study I, Jokinen et al found that cognitive impairments were common 
even after successful clinical recovery.  
Repeated neuropsychological assessments during the two-year follow-up 
period allow comparing the usefulness of cognitive data gathered at baseline 
and later on. Importantly, post-stroke cognitive impairments could be reliably 
detected instantaneously after the stabilization of the acute phase. Therefore, 
given the critical period of heightened plasticity after stroke (Jenkins & 
Merzenich, 1987; Kleim & Jones, 2008; Musicco et al., 2003; Salter et al., 
2006), the early timing of neuropsychological assessments has an indispensable 
benefit over any later timing. Late phase assessments for sure can provide 
coherent and reliable information and serve multiple purposes in patient care. 
However, only a balanced early timing of a neuropsychological assessment 
enables utilizing cognitive data during this transient period of most efficient 
recovery and rehabilitation. 
According to Study II, early neuropsychological assessments can also serve 
stroke treatment in the prediction of vocational outcome. This finding is a 
valuable addition to previous research, which has emphasised baseline cognitive 
impairments as predictors of the later cognitive (Nys, van Zandvoort, de Kort, 
van der Worp et al., 2005) and functional outcomes (Barker-Collo & Feigin, 
2006; Feigin et al., 2008) and quality of life after stroke (Hochstenbach et al., 
2001; Nys et al., 2006).  
The association of both the clinical (NIHSS) severity of stroke and functional 
impairments (Barthel Index) with the vocational outcome was clear in Study II 
in conjunction with previous studies (Busch, Coshall, Heuschmann, McKevitt, & 
Wolfe, 2009; Neau et al., 1998). Study II also replicated previous research 
suggesting other than health-related factors, such as age, education and type of 
work, to affect the post-stroke vocational outcome (Howard et al., 1985; Tanaka 
et al., 2011). Study II was the first to adjust the analysis of these diverse factors 
for the effect of cognitive impairments, which led to the proposal that the 
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cognitive severity of stroke was an even more important predictor. Returning to 
work has been proposed as a global outcome measure that assesses the efficacy 
of multidisciplinary treatment strategies for any working individual who 
develops a stroke (Singhal & Lo, 2014). Should return to work claim such a 
linchpin role as an outcome measure of stroke in the working-aged, the findings 
of Study II set early neuropsychological assessments as an essential part of 
multidisciplinary post-stroke treatment planning. 
The inability of many working-aged stroke patients to return to work is a 
major contributor to stroke-related productivity losses. As an outcome measure, 
however, returning to work remains potentially insufficient. It excludes an 
evident portion of the study population: those outside of the workforce already 
at the time of their strokes. Yet there are massive socio-economic discrepancies 
in stroke incidence, treatment and outcome (Addo et al., 2012), income level 
being inversely related to the risk of stroke. Arguably, the need to describe the 
indirect consequences of stroke without excluding some of those potentially 
suffering harder from stroke is evident. Study III presented one of the first 
attempts to measure and predict stroke-related productivity losses including but 
not restricted to employment. In study III, stroke-related income supplement 
use was introduced as a novel parameter to evaluate the productivity-related 
variation among working-aged stroke patients without the prerequisite of 
employment. The idea was that the use of income supplements, when 
specifically granted on the basis of the stroke, could be taken as a sign of 
productivity-related disability in both employed and others as well. In the study, 
approximately every third patient received disability-based benefits at the three-
year follow-up. This observation is in concordance with the post-stroke 
unemployment data from Netherlands (Maaijwee et al., 2014). Unlike in the 
Maaijwee et al study, Study III utilized multiple health-related factors in the 
prediction of disability payment usage. As a result, the use of stroke-related 
income supplements was most effectively predicted by atrial fibrillation and 
cognitive impairment, both well-known effectors of stroke outcome.  
Atrial fibrillation, which is under-diagnosed, undertreated, and associated 
with large strokes and increased early mortality, is a leading cause of stroke 
 
 
59 
(Lamassa et al., 2001). That atrial fibrillation appeared also as the strongest 
health-related predictor of stroke-related income supplement use, seems to be a 
logical continuum. Yet the finding is noteworthy considering that incidence of 
atrial fibrillation increases with age (Wolf, Abbott, & Kannel, 1991) and that in 
this cohort of working-aged stroke survivors the prevalence of atrial fibrillation 
was as low as 11% (all cardiac aetiologies 21%).  
Several factors relating to the incident stroke were compared in the 
prediction of income supplement usage, including clinical severity, functional 
impairment, and lesion characteristics. From the baseline through the follow-
up, the most effective stroke-related effector of disability payment use was 
cognitive impairment, while the effectors remained multifactorial. Thus, 
expanding the evaluation of stroke-related productivity losses from the 
employed (Study II) to the whole cohort (Study III) did not alter the central role 
of cognitive impairments to the indirect costs of stroke, nor did it change the 
need for a multifactorial account.  
The findings of Study I-III bear relevance to both understanding the global 
burden of stroke and treatment planning. Encouragingly good clinical and 
functional recovery commonly seen after contemporary acute stroke treatment 
has not stopped the accumulation of socio-economic burden of stroke (Brown et 
al., 2006; Feigin et al., 2015). Aging population is the most important factor 
behind the increase, but not the only one (Feigin et al., 2015). The incidence of 
stroke among the younger population in the middle of their most demanding 
and productive years is growing (Krishnamurthi et al., 2015). As cognitive 
impairments seem to mediate post-stroke productivity losses, the growing 
understanding of post-stroke cognitive impairments can help in treating the 
accumulation of stroke burden. 
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5.4 Generalizability 
The patients in this study were working-aged (18–65 years) and suffering their 
first-ever ischaemic stroke. The majority of strokes occur in elderly patients, 
and every sixth stroke is recurring (Aivoinfarkti. Cerebral infarction [stroke]: 
Current Care Guidelines Abstract, 2011). In what sense then can studying 
working-aged patients inform understanding of stroke in general? First, 
focusing on these relatively young stroke survivors suffering their first-ever 
stroke supported the aim to minimize the bias caused by potential pre-existing 
cognitive impairment, from which it is generally impossible to gather explicit 
knowledge in a clinical setting. Second, stroke in the working-aged population 
disproportionally raises the total socio-economic burden of stroke (Brown et al., 
2006). Arguably the working-aged subgroup bears relevance to stroke research 
in general. 
Being relatively young, suffering their first-ever stroke, and receiving modern 
acute stroke care, the cohort’s favourable clinical and functional outcome was 
expected. Yet the small amount of very severely injured patients in the sample 
requires evaluation of the study setting and success in the consecutive 
recruitment of patients. During recruitment, six patients were excluded because 
they were too severely injured to complete the neuropsychological assessment. 
These exclusions certainly cause a slight underestimation of the median NIHSS 
score and Barthel Index for the purpose of generalizing the results to the general 
stroke population. However, as one of the main arguments of this set of studies 
is that clinically relevant cognitive impairments are relatively prevalent of 
among patients with less severe strokes, the good clinical and functional 
recoveries are not an argument against the generalizability of the results. In fact, 
due to the good clinical and functional outcomes, this working-age cohort 
presents an essential stroke subpopulation at risk of suffering from non-
detected cognitive impairments.  
The successful clinical and functional recovery of the cohort also relates to 
the generalizability of the results regarding the multivariate model of return to 
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work after stroke, where cognitive impairments most effectively predicted the 
return to work after stroke. The mild clinical impairments of the cohort raise the 
question of whether the predictive model would emphasize different aspects of 
stroke severity in a cohort with more prominent clinical impairments. This 
concern is emphasized given that 21 dropouts from the six-month follow-up 
exhibited higher median NIHSS scores than the participants of the six-month 
follow-up. As a sum score of the multiple gross neurological impairments, the 
NIHSS captures many of the obvious hindrances of working life. In a cohort 
with frequent gross neurological impairments, a high NIHSS score would 
certainly offer a powerful estimate for the vocational outcome. This consecutive 
cohort was designed to be representative of working-aged patients with their 
first-ever stroke who have received high standard acute stroke treatment. When 
leaving acute care, 61 % of the patients in the present study had a NIHSS score 
of zero or one. Nevertheless, the patients’ cognitive impairments were disabling 
and frequent enough to explain the rather adverse return-to-work rate. Perhaps 
symptomatically, those dropouts from the six-month follow-up, with higher 
baseline median NIHSS scores, also had more frequent impairments in 
psychomotor speed. Indeed, in many cases, the cognitive impairments seem to 
be the primary health-related determinant of the vocational outcome, and gross 
neurological impairments are insensitive to more fine-grained yet debilitating 
cognitive impairment (Gottesman et al., 2010). 
Merely 41 % of the patients previously working full time in paid employment 
outside the house had returned to work six months after the stroke. The post-
stroke return-to-work rates vary noticeably among different studies due to 
different definitions of work (Daniel et al., 2009; Treger et al., 2007). Studies 
defining work similarly as paid employment outside the house typically report 
approximately half of the patients returning to work (Daniel et al., 2009). The 
lower return-to-work rate of this study could possibly reflect between-country 
differences, for example, in the availability and duration of disability-based 
income supplements.  
External validity of the results depends heavily on the clinical relevance of 
cognitive impairment definitions. A thorough neuropsychological assessment 
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was used to collect cognitive data. Each cognitive domain was measured with 
three separate tests, and defective test performance was defined in relation to 
carefully collected control group performance. To denote impairment, at least 
two out of the three within-domain test scores were required to be defective. 
This method of chasing a repeating pattern of defective test performance 
instead of single deviant test scores mimics clinical neuropsychological decision 
making and significantly narrows the criteria for a defective performance. As a 
consequence of this conservative method, prevalence of baseline cognitive 
impairments was somewhat lower (57 %) than previously reported 
(approximately 70 %) (Gottesman & Hillis, 2010).  
The structures of healthcare systems, the levels of income supplementation 
and the durations of these benefits vary significantly across countries. The 
present study was conducted in Finland, which to date has had a relatively 
strong socio-economic support system. Thus, to assess whether the results are 
applicable and relevant to other countries with different social security support 
systems, some of the assumptions made in this study must be explained and 
delineated to indicate what has and has not been measured. 
First, the generalizability of the Study III’s results relies on the assumption 
that many, though not all, societies have a social security programme that 
contains an economic support mechanism for severe and enduring illnesses 
such as stroke. Second, the generalizability of the results relies on the 
assumption that there is measurable variation within a disability-based benefit 
programme, that is, not all benefactors obtain the same benefits irrespective of 
their condition. The variation between the support systems of different societies 
does not threaten the generalizability of the approach taken. As long as 
measurable variation within a disability-based benefit programme exists, 
evaluating stroke-related changes in income supplement use can provide a 
complementary perspective on stroke-related productivity. The expenses of 
disability-based benefits apparently vary both between and within countries 
because of varying income levels and many other factors. Rather than 
measuring the amount of money spent on stroke patients, Study III focused on 
factors that could predict differences in the length of time that the patients used 
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the income supplements. Obviously, the duration of these benefits varies 
between countries. In this Finnish cohort of working-aged patients who 
experienced a first-ever ischaemic stroke, stroke led to income supplement use 
for a mean of 11 months. In other countries, the mean time of stroke-related 
supplement use is likely to be different, but the variation can be measured and 
predicted with significant effectors. 
Study III results are not generalizable in the sense that the study could not be 
replicated in countries without a social security system that includes a 
mechanism to provide disability-based support. However, the need to 
understand stroke-related productivity losses more thoroughly than merely by 
the inability to work is pressing, irrespective of the social security policy at 
hand. Therefore, the results of Study III can still be relevant to societies without 
a disability support programme.  
5.5 Concluding remarks 
Productivity losses are crucial to the huge socio-economic burden of stroke. 
Cognitive impairments’ central role in mediating adverse stroke outcome is 
emerging and elucidating. Nevertheless, stroke research covering productivity 
and cognitive impairments are sparse. The aim of this study was to describe 
post-stroke cognitive impairments in terms of productivity-related recovery. 
The main findings were that clinically significant cognitive impairments were 
alarmingly common even among neurologically well-recovered patients, that 
cognitive impairments most effectively predicted return to work after stroke, 
and that together with atrial fibrillation, cognitive impairments also effectively 
predicted stroke-related income supplement use.  
There appears to be no safe limit for assuming intact cognition in stroke 
patients based on clinical recovery, a finding that has recently been replicated 
(Jokinen et al., 2015). Given the established possibilities to treat cognitive 
impairments after stroke (Cicerone et al., 2011) and the significance of cognitive 
impairments to stroke outcome (Barker-Collo & Feigin, 2006; Feigin et al., 
2008; Gottesman & Hillis, 2010; Hochstenbach et al., 2001; Jaillard et al., 
2009; Kotila et al., 1984; Nys, van Zandvoort, de Kort, van der Worp et al., 
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2005; Nys et al., 2006; Treger et al., 2007; Wiberg, Kilander, Sundstrom, 
Byberg, & Lind, 2012; Wozniak & Kittner, 2002), the benefits of early 
neuropsychological assessments to treatment planning are emphasised. Finally, 
according to Studies II-III, effectors of post-stroke productivity are 
multifactorial by nature and strongly associated with cognitive impairments.  
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